Operation Desert Shield

Hyams K, Hanson K, Wignall F et al. (1995). The impact of infectious diseases on the health of US troops deployed to the Persian Gulf during Operations Desert Shield and Desert Storm. Clin Infect Dis, 20, 1497-1504. 

C. Prophylaxis. Ribavirin is a synthetic, water soluble, colorless nucleoside available as an injectable solution for IV administration or in a capsule form for oral administration. Oral and intravenous ribavirin are IND products and would be available only on protocol with informed consent. Ribavirin was approved for use in Operation Desert Shield/Storm, Somalia and Korea. Monitoring for anemia is suggested. In the case of a suspected biological attack, ribavirin could be considered for therapy as well as prophylaxis. 

Birth outcomes for 579,931 active duty military personnel deployed for at least one day to Operations Desert Shield/Desert Storm from August 8, 1990, to July 31, 1991, were compared to that for 700,000 service members occurring in a similar time frame. Information was obtained from hospital-recorded. International... 

Writer, J.V, DeFraites, R.F., and Brundage, J.F., Comparative mortahty among U.S. military personnel in the Persian Gulf and worldwide during Operations Desert Shield and Desert Storm, JAMA, 275, 18, 1996. 

DeFraites, R.F., Wanat, E.R., and Norwood, A.E., Report, investigation of a suspected outbreak of an unknown disease among veterans of Operation Desert Shield/Storm, 123d Army Reserve Command, Fort Benjamin Harrison, IN, April 1992, Epidemiology Consultant Service (EPICON), Division of Preventive Medicine, Walter Reed Army Institute of Research, Washington, DC, June 15, 1992. 

Operation Desert Shield/Desert Storm, History of Participation of the U.S. Army Environmental Hygiene Agency, Aberdeen Proving Ground, MD, August 7, 1990-DecemberSl, 1991. 

The first U.S. troops arrived in the southwest Asia theater of operations in August 1990 during the preparatory period referred to as Operation Desert Shield, the period immediately... 

Wade JV, Gum RM, Dunn MA. Medical chemical defense in Operations Desert Shield and Desert Storm. J US Army Med Dept. 1992 PB8 92 1/2 34-36. 

During Operation Desert Shield, the build-up phase of the Persian Gulf War (fall and winter, 1990) after Iraq invaded and occupied Kuwait, the United States and the coalition of allies faced the threat of biological and chemical warfare. Fortunately, Saddam Hussein did not use unconventional weapons, but the allies believe that he retained this capability after his defeat. 

Emonson, D. L., Vanderbeek, R. D. (1995). The use of dextroamphetamine in support of tactical air operations during Operation Desert Shield/Storm. Nvzatt o , Space, and Environmental Medicine, 66, 260-263. 

Schwarzkopf, It Doesn t Take a Hero, p.439 Gen. H.N. Schwarzkopf, Hearings on Operation Desert Shield/Desert Storm before the Committee on Armed Services United States Senate, 102nd Congress, first session, 12 June 1991,p.349. ... 

Horner, Statement included in Hearings...Operation Desert Shield/Desert Storniy p.243 R. Highfield, Iraq s Arsenal of Horror Still More Weapons Remain, The Daily Telegraph, 25 May 1992, p.l4. 

Horner, Statement included in Hemngs...Operation Desert Shield/Desert Storm, p.243 DoD, Conduct of the Persian Gulf War, p,345. 

T. Frame, RAN Ready for Chemical Attack , Asia-Pacific Defence Reporter, vol.xvii, no.9 (March 1991), pp.12-13 DoD, Conduct of the Persian Gulf War, p.l07 Schwarzkopf, Hearings...Operation Desert Shield/Desert Storm, p.334 Otter, Chemical Warfare Defence , p.48. 

---